ライフサイエンスコーパス: anti-inflammatory drug

1 to cyclooxygenase-1 inhibitors (nonsteroidal anti-inflammatory drugs).

2 from 9 (benzodiazepines) to 70 (nonsteroidal anti-inflammatory drugs).

3 medications such as aspirin or nonsteroidal anti-inflammatory drugs).

4 ng candidate for further development into an anti-inflammatory drug.

5 nt with controlled release of the payload of anti-inflammatory drug.

6 jury induced by indomethacin, a nonsteroidal anti-inflammatory drug.

7 both ionization states of this nonsteroidal anti-inflammatory drug.

8 treatment of pericarditis is represented by anti-inflammatory drugs.

9 urses of oral contraceptives or nonsteroidal anti-inflammatory drugs.

10 d as a starting point for the development of anti-inflammatory drugs.

11 threshold of a new era of mPGES-1-targeting anti-inflammatory drugs.

12 bitors as a safe alternative to nonsteroidal anti-inflammatory drugs.

13 es the synthesis of a number of nonsteroidal anti-inflammatory drugs.

14 inst gastric damage induced by non-steroidal anti-inflammatory drugs.

15 epresent an important family of nonsteroidal anti-inflammatory drugs.

16 e now worldwide availability of nonsteroidal anti-inflammatory drugs.

17 of toxicity and to ultimately develop safer anti-inflammatory drugs.

18 medicine with available bronchodilators and anti-inflammatory drugs.

19 et for a novel class of cytokine-suppressive anti-inflammatory drugs.

20 lfonylureas, aspirin, and other nonsteroidal anti-inflammatory drugs.

21 es were stimulated with related nonsteroidal anti-inflammatory drugs.

22 hout the side effects of currently available anti-inflammatory drugs.

23 lerance or contraindication to non-steroidal anti-inflammatory drugs.

24 esponse or contraindication to non-steroidal anti-inflammatory drugs.

25 Pretreatment with the non-steroidal anti-inflammatory drug, 2-cyano-3,12-dioxooleana-1,9(11)

26 , 14% administer post operative nonsteroidal anti-inflammatory drugs, 28% administer postoperative an

27 ia (31.1% vs 12.9%; P < 0.001), nonsteroidal anti-inflammatory drugs (33.5% vs 14.4%; P < 0.001), and

28 d by topical steroids (86%) and nonsteroidal anti-inflammatory drugs (66%), and accounted for 26%, 37

29 ingestion of aspirin and other nonsteroidal anti-inflammatory drugs, a disorder termed aspirin-exace

30 tients are usually treated with nonsteroidal anti-inflammatory drugs, acetaminophen, opioids, or skel

31 Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) is a tra

32 ntihypertensive medications and nonsteroidal anti-inflammatory drugs (adjusted odds ratio [aOR], 0.97

33 k transformation during chronic nonsteroidal anti-inflammatory drug administration, this masks the co

34 examined whether dimethyl fumarate (DMF), an anti-inflammatory drug already in clinical use for multi

35 ow microsphere (HM) carrier that contains an anti-inflammatory drug, an acid precursor consisting of

36 roach was employed to prepare a nonsteroidal anti-inflammatory drug analogue.

37 re was the occurrence of NIU with the use of anti-inflammatory drugs and adjudication by an ophthalmo

38 osure to SSRIs, as is done with nonsteroidal anti-inflammatory drugs and aspirin.

39 Some COX inhibitors (i.e. nonsteroidal anti-inflammatory drugs and coxibs) and common fatty aci

40 Accordingly, nonsteroidal anti-inflammatory drugs and NADPH oxidase inhibitors abr

41 potassium-sparing diuretics or nonsteroidal anti-inflammatory drugs and oral potassium and magnesium

42 treated melanoma transplants with nonsteroid anti-inflammatory drugs and show that higher melanoma di

43 s or older, lack of exposure to nonsteroidal anti-inflammatory drugs and statins.

44 ess to a variety of enantiopure nonsteroidal anti-inflammatory drugs and to alpha-amino acid derivati

45 ng and taking analgesic agents (nonsteroidal anti-inflammatory drugs and weak opioids such as tramado

46 moking, body mass index, use of nonsteroidal anti-inflammatory drugs) and symptoms of gastroesophagea

47 of potential nephrotoxins (eg, nonsteroidal anti-inflammatory drugs), and adjustments to drug dosing

48 ne, intravenous immunoglobulin, nonsteroidal anti-inflammatory drugs, and cyclosporine, can be effect

49 s, female sex, smoking, use of non-steroidal anti-inflammatory drugs, and Helicobacter pylori infecti

50 Treatment usually involves analgesics, anti-inflammatory drugs, and supportive care.

51 Unlike antipyretic non-steroidal anti-inflammatory drugs, APAP elicits hypothermia in add

52 ow-molecular-weight heparin and nonsteroidal anti-inflammatory drugs are associated with lower rates

53 Since anti-inflammatory drugs are beneficial as adjuvants to c

54 Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are common causes, demographic d

55 Oral nonsteroidal anti-inflammatory drugs are not recommended for long-ter

56 adverse effects, glucocorticoids (GC, potent anti-inflammatory drugs) are used extensively in clinica

57 er pharmacologic treatment with nonsteroidal anti-inflammatory drugs as first-line therapy, or tramad

58 report that the combined low-dose use of two anti-inflammatory drugs, aspirin and triptolide, reduces

59 Some manifestations, such as nonsteroidal anti-inflammatory drug-associated angioedema and serum s

60 We examined the role of RGS4 in nonsteroidal anti-inflammatory drug-associated bronchoconstriction by

61 atus, and use of analgesics and nonsteroidal anti-inflammatory drugs at 1 and 12 months.

62 fluent exposome of fish, 6 were nonsteroidal anti-inflammatory drugs but with plasma concentrations t

63 NSAIDs are commonly used anti-inflammatory drugs, but their effects on TIC and ou

64 To investigate whether anti-inflammatory drugs can modulate the ductular respon

65 The anti-inflammatory drug candidate, 6-shogaol, has demonst

66 sease, and NFkappaB inhibitors are promising anti-inflammatory drug candidates.

67 pertensives, aspirin, steroids, nonsteroidal anti-inflammatory drugs, Charlson Comorbidity Index scor

68 be responsive to glucocorticoid, a class of anti-inflammatory drugs commonly used in DMD patients.

69 dosing regimen of the most effective topical anti-inflammatory drugs, corticosteroids, are still a ma

70 ventions such as acetaminophen, nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 inhibitors, ga

71 ventions such as acetaminophen, nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 inhibitors, ga

72 ogy and will be an important asset in future anti-inflammatory drug design.

73 e been suggested, ranging from non-steroidal anti-inflammatory drugs, drugs for neuropathic pain, opi

74 Nonsteroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, and na

75 Pretreating animals with anti-inflammatory drugs etanercept (TNFalpha inhibitor),

76 Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (

77 on was stratified by asthma or non-steroidal anti-inflammatory drug-exacerbated respiratory disease s

78 A237T) or by application of the nonsteroidal anti-inflammatory drug flufenamic acid (FFA; 2-{[3-(trif

79 was applied to an efficient synthesis of the anti-inflammatory drug flurbiprofen.

80 MARDs), or at least 4 weeks of non-steroidal anti-inflammatory drugs for psoriatic arthritis.

81 ant to current therapies, and even effective anti-inflammatory drugs frequently do not repair damaged

82 Preadmission use of statins, nonsteroidal anti-inflammatory drugs, glucocorticoids, or combination

83 ective for acute low back pain, nonsteroidal anti-inflammatory drugs had smaller benefits for chronic

84 ble phosphodiesterase 4 (PDE4) inhibitors as anti-inflammatory drugs has been going on for decades.

85 the development of IL-37 and IL-38 as novel anti-inflammatory drugs has not been considered adequate

86 Mefenamic acid, a nonsteroidal anti-inflammatory drug, has been identified as an I (Ks)

87 ) showed that oral steroids and nonsteroidal anti-inflammatory drugs have similar analgesic effective

88 carprofen (CPF), a veterinary non-steroidal anti-inflammatory drug, have synergistic antimicrobial a

89 s to beta-lactams, aspirin, and nonsteroidal anti-inflammatory drugs; however, the clinical utility o

90 % of patients with a suspected non-steroidal anti-inflammatory drug hypersensitivity (NSAIDH), challe

91 induced by either morphine or the nonsteroid anti-inflammatory drug ibuprofen increased CPP scores in

92 ted potential therapy with the non-steroidal anti-inflammatory drug ibuprofen.

93 lpropionic acids (including the nonsteroidal anti-inflammatory drugs ibuprofen and flurbiprofen), as

94 sing Fh15 as an excellent alternative for an anti-inflammatory drug in preclinical studies in the nea

95 e that therapeutic strategies using existing anti-inflammatory drugs in combination with current trea

96 Glucocorticoids are the most frequently used anti-inflammatory drugs in dermatology.

97 hromatographic determination of nonsteriodal anti-inflammatory drugs in mu-EME processed complex samp

98 Reactions to aspirin and nonsteroidal anti-inflammatory drugs in patients with aspirin-exacerb

99 ions of these findings, including studies of anti-inflammatory drugs in schizophrenia, describe areas

100 ikely to improve in males on statins but not anti-inflammatory drugs in the triclosan group versus th

101 context-dependent effect of the nonsteroidal anti-inflammatory drug indomethacin (IND) on MDSCs, depe

102 -exacerbated cutaneous disease, nonsteroidal anti-inflammatory drug-induced urticaria/angioedema (NIU

103 Nonsteroidal anti-inflammatory drugs-induced urticaria/angioedema doe

104 Diclofenac, a nonsteroidal anti-inflammatory drug inhibiting COX-2, increased anast

105 Nonsteroidal anti-inflammatory drugs interfere with the metabolism of

106 Rectal indomethacin, a nonsteroidal anti-inflammatory drug, is given to prevent pancreatitis

107 cer risk and recurrence, suggesting that the anti-inflammatory drug may exert effects on CSCs.

108 Nonsteroidal anti-inflammatory drugs may impair wound healing and inc

109 ent with continuous pain that is relieved by anti-inflammatory drugs may point to an osteoid osteoma.

110 Treatment of PA14 with the FDA-approved anti-inflammatory drug mesalamine, which has recently be

111 treatments such as antibiotics (rifaximin), anti-inflammatory drugs (mesalazine) and probiotics, alo

112 st-traumatic stress disorder (PTSD) and that anti-inflammatory drugs might be a new treatment strateg

113 ebroventricular infusion of indomethacin, an anti-inflammatory drug, mitigates the effect of ALI on f

114 h ionized and neutral states of nonsteroidal anti-inflammatory drugs must be considered to clarify th

115 therapies, which have included non-steroidal anti-inflammatory drugs, must take into account biochemi

116 (NH3)5(L)](BF4)3 containing the nonsteroidal anti-inflammatory drugs nicotinic acid (Hnic) and its is

117 the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added to topical steroid

118 hip between early postoperative nonsteroidal anti-inflammatory drug (NSAID) administration and postop

119 tion of PGE2 production through nonsteroidal anti-inflammatory drug (NSAID) administration just after

120 Reported nonsteroidal anti-inflammatory drug (NSAID) allergies may predispose

121 Treatment with a NO-donating non-steroidal anti-inflammatory drug (NSAID) alleviates this ischaemia

122 Barrett's esophagus (BE), and non-steroidal anti-inflammatory drug (NSAID) bleeding prophylaxis.

123 hydrase inhibitor in 6 eyes and nonsteroidal anti-inflammatory drug (NSAID) drops in 2 eyes.

124 Nonsteroidal anti-inflammatory drug (NSAID) exacerbated cutaneous dis

125 lofenac sodium is a widely used nonsteroidal anti-inflammatory drug (NSAID) for relief of inflammator

126 leotide polymorphisms (SNPs) in nonsteroidal anti-inflammatory drug (NSAID) metabolism and related pa

127 In eyes with nonsteroidal anti-inflammatory drug (NSAID) monotherapy (n = 157), CR

128 ation of the minimally modified nonsteroidal anti-inflammatory drug (NSAID) naproxen.

129 ne acetate (PA) alone or with a nonsteroidal anti-inflammatory drug (NSAID) or intraoperative subconj

130 ether short-term use of topical nonsteroidal anti-inflammatory drug (NSAID) or steroid therapy affect

131 idence links certain aspects of nonsteroidal anti-inflammatory drug (NSAID) pharmacology with acid-se

132 RXRalpha modulator derived from nonsteroidal anti-inflammatory drug (NSAID) sulindac, suppresses the

133 microbiota and indomethacin, a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygen

134 Non-steroidal anti-inflammatory drug (NSAID) treatment suppresses para

135 lopidogrel, ticagrelor) but not nonsteroidal anti-inflammatory drug (NSAID) treatment with sulindac p

136 showed no relationship between nonsteroidal anti-inflammatory drug (NSAID) use and AD.

137 Nonsteroidal anti-inflammatory drug (NSAID) use is recommended to be

138 y repeating the analyses in non-nonsteroidal anti-inflammatory drug (NSAID) users (n = 315).During a

139 roline complexes containing the nonsteroidal anti-inflammatory drug (NSAID), indomethacin, is reporte

140 emonstrates that daily use of a nonsteroidal anti-inflammatory drug (NSAID), which inhibits COX-2 act

141 Multitarget nonsteroidal anti-inflammatory drug (NSAID)-carbonic anhydrase inhibi

142 ither diagnose or differentiate nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory d

143 Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory d

144 PGE(2) ) has been postulated in nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory d

145 We used an animal model of non-steroidal anti-inflammatory drug (NSAID)-induced SI epithelial inj

146 Nonsteroidal anti-inflammatory drug (NSAID)-induced urticarial and an

147 of bronchospasm related to ASA/nonsteroidal anti-inflammatory drugs (NSAID) intake.

148 on or tamponade, and failure of nonsteroidal anti-inflammatory drug [NSAID] treatment) indicate a poo

149 ics (7.4%), opiates (6.8%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (3.5%).

150 inst aspirin (n = 12) and other nonsteroidal anti-inflammatory drugs (NSAIDs) (n = 8), and IR to biol

151 10 trials evaluated the use of nonsteroidal anti-inflammatory drugs (NSAIDs) (n=4,258) and 4 investi

152 nce IOP spikes than those using nonsteroidal anti-inflammatory drugs (NSAIDs) alone (hazard ratio, 3.

153 Concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin in

154 Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most comm

155 Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most freq

156 Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most prev

157 Nonsteroidal anti-inflammatory drugs (NSAIDs) are assumed to increase

158 of malignant pleural effusion, nonsteroidal anti-inflammatory drugs (NSAIDs) are avoided because the

159 Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective, widely u

160 Nonsteroidal anti-inflammatory drugs (NSAIDs) are efficacious in clos

161 Non-steroidal anti-inflammatory drugs (NSAIDs) are known gamma-secreta

162 bout cardiovascular toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) are sparse.

163 Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequent m

164 Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequent t

165 ylaxis induced by LTPs requires nonsteroidal anti-inflammatory drugs (NSAIDs) as a triggering cofacto

166 Are nonsteroidal anti-inflammatory drugs (NSAIDs) associated with better

167 Clinical Question: Are nonsteroidal anti-inflammatory drugs (NSAIDs) associated with greater

168 Are topical nonsteroidal anti-inflammatory drugs (NSAIDs) associated with reduced

169 Nonsteroidal anti-inflammatory drugs (NSAIDs) can damage the gastroin

170 Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bronchospasm in s

171 Non-steroidal anti-inflammatory drugs (NSAIDs) cause damage in the sma

172 miologic evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) contribute to more seve

173 I); however, concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) could pose safety conce

174 Non-steroidal anti-inflammatory drugs (NSAIDs) damage the gastrointest

175 s acetaminophen/paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) for mild cancer pain.

176 The role of topical nonsteroidal anti-inflammatory drugs (NSAIDs) for the reduction of oc

177 gressive consumption growth of non-steroidal anti-inflammatory drugs (NSAIDs) has progressively raise

178 n rapid reversible, competitive nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to inhi

179 Nonsteroidal anti-inflammatory drugs (NSAIDs) have many physiologic e

180 Nonsteroidal anti-inflammatory drugs (NSAIDS) have received increasin

181 st from using aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) in relation to survival

182 Ion-exchange removal of nonsteroidal anti-inflammatory drugs (NSAIDs) in synthetic urine can

183 subcellular mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) induce apoptosis in gas

184 Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase-

185 Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with lowe

186 Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) is of great concern bec

187 We evaluated the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on survival in a PIK3CA

188 ught to evaluate the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on T-cell activation of

189 ffect of routine use of topical nonsteroidal anti-inflammatory drugs (NSAIDs) on the incidence of pos

190 r hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) proposed by the Europea

191 e of aspirin and/or non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk of sev

192 ll intestinal damage induced by nonsteroidal anti-inflammatory drugs (NSAIDs) remains an under-recogn

193 Topical nonsteroidal anti-inflammatory drugs (NSAIDs) significantly reduced t

194 ated the remarkable efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, napr

195 Targeting of COX-1/2 using nonsteroidal anti-inflammatory drugs (NSAIDs) such as the COX-1/2 inh

196 Although nonsteroidal anti-inflammatory drugs (NSAIDs) target primarily cycloo

197 ion due to prior conjugation to nonsteroidal anti-inflammatory drugs (NSAIDs) to access H(2)S-NSAID h

198 The ability of nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit cyclooxygena

199 respiratory infection (ARI) and nonsteroidal anti-inflammatory drugs (NSAIDs) use could trigger acute

200 Non-steroidal anti-inflammatory drugs (NSAIDs) use in the year prior t

201 Topical steroids and oral nonsteroidal anti-inflammatory drugs (NSAIDs) were used as the first

202 ng the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs) when used for arthritis

203 oskeletal injuries with topical nonsteroidal anti-inflammatory drugs (NSAIDs) with or without menthol

204 The use of nonsteroidal anti-inflammatory drugs (NSAIDs) with oral anticoagulant

205 trolled) shows that colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), and corticosteroids re

206 trolled) shows that colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), and corticosteroids re

207 ump inhibitors (PPIs), aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and selective serotoni

208 Oxicams are widely used nonsteroidal anti-inflammatory drugs (NSAIDs), but little is known ab

209 eropathy associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs), but there have been fe

210 uine serum albumin (ESA) of two nonsteroidal anti-inflammatory drugs (NSAIDs), diclofenac (Dic) and n

211 ent literature on the safety of nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and tr

212 llions of people worldwide take nonsteroidal anti-inflammatory drugs (NSAIDs), often in conjunction w

213 nicians choose corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine to treat

214 Nonsteroidal anti-inflammatory drugs (NSAIDs), the medications most c

215 ated for prophylaxis, including nonsteroidal anti-inflammatory drugs (NSAIDs), which are potent inhib

216 iplatelet drugs or nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), which further increase

217 nt from those of agents such as nonsteroidal anti-inflammatory drugs (NSAIDs).

218 ate response or intolerance to non-steroidal anti-inflammatory drugs (NSAIDs).

219 usitis compared with placebo or nonsteroidal anti-inflammatory drugs (NSAIDs)?

220 ives, 4 diabetes medications, 2 nonsteroidal anti-inflammatory drugs [NSAIDs] or aspirin, 17 hormones

221 therapeutic areas: analgesia (non-steroidal anti-inflammatory drugs [NSAIDs]), diabetes (metformin),

222 ugs such as corticosteroids and nonsteroidal anti-inflammatory drugs, often accompanied by dose-depen

223 uch diseases focus on systemically delivered anti-inflammatory drugs, often leading to detrimental si

224 The effect of anti-inflammatory drugs on the development of coronary a

225 ter the intake of drugs such as nonsteroidal anti-inflammatory drugs, opioids and drugs in the periop

226 programming, blockade of these pathways with anti-inflammatory drugs or components of the nucleosome

227 ians and patients should select nonsteroidal anti-inflammatory drugs or skeletal muscle relaxants (mo

228 macological inhibitors, such as nonsteroidal anti-inflammatory drugs or small interfering RNAs (siRNA

229 al contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, al

230 her treated with dexamethasone or meloxicam (anti-inflammatory drugs) or left untreated.

231 o acetaminophen, phenprocoumon, nonsteroidal anti-inflammatory drugs, or autoimmune hepatitis) or pat

232 ent or combined use of statins, nonsteroidal anti-inflammatory drugs, or glucocorticoids.

233 Successful RA treatment with anti-inflammatory drugs partially reverses the oral micr

234 e measured the derivatives of the well-known anti-inflammatory drug Piroxicam using THz spectroscopy

235 .65; 95% CI, 2.34-2.99), use of nonsteroidal anti-inflammatory drugs plus opioids (OR, 1.84; 95% CI,

236 lar treatments were superior to nonsteroidal anti-inflammatory drugs, possibly because of the integra

237 Leflunomide is an anti-inflammatory drug primarily used for treating rheum

238 quid), and potential cofactors (nonsteroidal anti-inflammatory drugs, protonic pump inhibitors, exerc

239 Baseline and nonsteroidal anti-inflammatory drug reaction clinical data were corre

240 importantly, treatment with two FDA-approved anti-inflammatory drugs reduced brain inflammation, rest

241 Ibuprofen, a non-steroidal anti-inflammatory drug, rescued female embryos that cont

242 se risks for SP included use of nonsteroidal anti-inflammatory drugs (RR, 0.77; 95% CI, 0.65-0.92) or

243 er evaluation of novel selenium-nonsteroidal anti-inflammatory drug (Se-NSAID) hybrid molecules are r

244 Placebo-controlled trials of nonsteroidal anti-inflammatory drugs selective for inhibition of cycl

245 However, administration of anti-inflammatory drugs shortly after injury was not eff

246 ral therapy (cART) together with adjunctive "anti-inflammatory" drugs show no improvement over cART a

247 iovascular adverse effects than nonsteroidal anti-inflammatory drugs specific for inhibition of cyclo

248 ied include aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, statins, agents that target met

249 C-reactive protein, and use of nonsteroidal anti-inflammatory drugs, statins, and multivitamins.

250 Evidence supports the use of anti-inflammatory drugs such as acetaminophen/paracetamo

251 s are common adverse effects of nonsteroidal anti-inflammatory drugs such as acetylsalicylic acid (AS

252 mmatory diseases involves a long-term use of anti-inflammatory drugs such as corticosteroids and nons

253 Nonsteroidal anti-inflammatory drugs such as sulindac inhibit Wnt sig

254 The anti-inflammatory drug sulfasalazine programs macrophage

255 The reaction was tested with the anti-inflammatory drug sulindac and its metabolite, suli

256 expression are partially ameliorated by the anti-inflammatory drug sulindac and largely prevented by

257 The non-steroidal anti-inflammatory drug sulindac decreases size and numbe

258 We also found that the anti-inflammatory drugs sulindac sulfide and sulindac su

259 ied porcine PS combined with the hydrophobic anti-inflammatory drug Tacrolimus (TAC), a calcineurin i

260 ely to evaluate the potential of TPL-2 as an anti-inflammatory drug target.

261 As a result, the 14 anti-inflammatory drugs that have regulatory approval fo

262 The use of nonsteroidal anti-inflammatory drugs that inhibit cyclooxygenase (COX

263 Moreover, there is lack of effective anti-inflammatory drugs that meet the clinical requireme

264 Glucocorticoids (GCs) are potent anti-inflammatory drugs, the secretion of which is media

265 Nonsteroidal anti-inflammatory drug therapy was effective in reducing

266 tihypertensive medications and non-steroidal anti-inflammatory drugs therapy) as well as 4 dietary ex

267 proresolving mediators and how together with anti-inflammatory drugs, they could decrease inflammatio

268 the shell wall of the HMs and releasing the anti-inflammatory drug to the problematic site, eventual

269 nsider the pharmacokinetics of non-steroidal anti-inflammatory drugs to determine the optimal timing

270 utrophils as a universal platform to deliver anti-inflammatory drugs to promote tissue regeneration i

271 l. now report on the use of indomethacin, an anti-inflammatory drug, to sensitize therapy-resistant m

272 e not met, a trial of a topical nonsteroidal anti-inflammatory drug, tramadol, or both is recommended

273 temic vascular dysfunction with nonsteroidal anti-inflammatory drug usage.

274 ly active, not smoke, and avoid nonsteroidal anti-inflammatory drug use except aspirin prescribed for

275 7 recommendation on aspirin and nonsteroidal anti-inflammatory drug use to prevent colorectal cancer

276 on, diabetes, periodontal status, statin and anti-inflammatory drug use, and smoking as covariates.

277 e, gender, socioeconomic status, non-steroid anti-inflammatory drug use, former ulcer and health beha

278 Nonsteroidal anti-inflammatory drugs use during ARI episodes, especia

279 Nonsteroidal anti-inflammatory drugs use during ARI was associated wi

280 6,088 statin user pairs, 2,886 nonsteroidal anti-inflammatory drug user pairs, 1,440 glucocorticoid

281 s, 1.00 (95% CI, 0.90-1.11) for nonsteroidal anti-inflammatory drug users, 0.97 (95% CI, 0.82-1.14) f

282 21.3% (95% CI, 19.8-22.9%) for nonsteroidal anti-inflammatory drug users, 17.4% (95% CI, 15.4-19.5%)

283 Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agen

284 d supplementation of cells with nonsteroidal anti-inflammatory drugs was able to restore the level of

285 nderlying prevention of cognitive decline by anti-inflammatory drugs, we first identified an early ob

286 s with asthma hypersensitive to nonsteroidal anti-inflammatory drugs were compared with aspirin-toler

287 Eyes receiving prophylactic nonsteroidal anti-inflammatory drugs were excluded.

288 ecified (cohort B) reactions to nonsteroidal anti-inflammatory drugs were identified as "possible AER

289 ematocrit, aspirin therapy, and nonsteroidal anti-inflammatory drugs were independently associated wi

290 ersonal sunscreen products, and nonsteroidal anti-inflammatory drugs were seen in both groups; 14 of

291 tial effects were ignored, oral nonsteroidal anti-inflammatory drugs were superior.

292 nd deuteration of nimesulide, a nonsteroidal anti-inflammatory drug, were realized through the late-s

293 Selective COX-2 inhibitors are non-steroidal anti-inflammatory drugs which directly target cyclooxyge

294 tment involves intravenous administration of anti-inflammatory drugs which have limited clinical outc

295 y are the molecular targets for nonsteroidal anti-inflammatory drugs, which are among the oldest and

296 Non-steroidal anti-inflammatory drugs, which inhibit the cyclooxygenas

297 , aspirin, corticosteroids, and nonsteroidal anti-inflammatory drugs), with ulcerated primary melanom

298 wn as an ideal target for next generation of anti-inflammatory drugs without the side effects of curr

299 e of the most widely prescribed nonsteroidal anti-inflammatory drugs worldwide.

300 n the most widely used immunosuppressive and anti-inflammatory drugs, yet substantial gaps exist in o